"[People] had been developing Arabidopsis microarrays for a number of years, and these were some of the first papers that published high-quality data with real biological conclusions," says Chris Town ...
The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...
- The United States Biomedical Advanced Research and Development Authority (BARDA) has announced Vaxxas will receive US$2 million (AU$3.2 million) as a Concept Stage Winner in its multi-stage $50 ...
In a paper published today in the journal PLOS ONE, a research team headed by Dr. Paul Wheeler from the Animal Health and Veterinary Laboratories Agency (AHVLA, Weybridge, UK) reported breakthrough ...
Scienion AG has announced milestone advancements in the EU MicroAqua research project, which is dedicated to developing a universal microarray for the evaluation of fresh-water quality. The prototype ...
Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results